Podder, V., Ranjan, T., Margolin, K., Maharaj, A., & Ahluwalia, M. S. (2024). Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review. Cancers, 16(23), 3929. https://doi.org/10.3390/cancers16233929
Chicago Style (17th ed.) CitationPodder, Vivek, Tulika Ranjan, Kim Margolin, Arun Maharaj, and Manmeet Singh Ahluwalia. "Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review." Cancers 16, no. 23 (2024): 3929. https://doi.org/10.3390/cancers16233929.
MLA (9th ed.) CitationPodder, Vivek, et al. "Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review." Cancers, vol. 16, no. 23, 2024, p. 3929, https://doi.org/10.3390/cancers16233929.